Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells

J Biol Chem. 2016 Nov 25;291(48):25280. doi: 10.1074/jbc.A116.750653.
No abstract available

Publication types

  • Published Erratum